Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume 54, Issue 7, Pages 691-698
Publisher
Oxford University Press (OUP)
Online
2016-05-10
DOI
10.1093/mmy/myw031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs
- (2018) Nuggehally R. Srinivas AMERICAN JOURNAL OF THERAPEUTICS
- Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach
- (2015) Meinolf Karthaus et al. ANNALS OF HEMATOLOGY
- Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review
- (2015) Hazem Elewa et al. CLINICAL PHARMACOKINETICS
- Dosing of antifungal agents in obese people
- (2015) Kenna D. Payne et al. Expert Review of Anti-Infective Therapy
- Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration
- (2015) Mahipal G. Sinnollareddy et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis
- (2014) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)
- (2014) Corrado Girmenia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients
- (2014) M. Mansour Ceesay et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK
- (2014) M. M. Ceesay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CYP2C19Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?
- (2014) Aniwaa Owusu Obeng et al. PHARMACOTHERAPY
- A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration
- (2013) Lewis Couchman et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity
- (2013) Yosuke Suzuki et al. CLINICA CHIMICA ACTA
- Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis
- (2013) Seyedmojtaba Seyedmousavi et al. Expert Review of Anti-Infective Therapy
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry
- (2012) L. Couchman et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Making sense of posaconazole therapeutic drug monitoring
- (2012) Michelle R. Ananda-Rajah et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The role of antifungal treatment in hematology
- (2012) J. A. Maertens et al. HAEMATOLOGICA
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- (2012) G. Krishna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
- (2011) Jeroen Walravens et al. CLINICAL PHARMACOKINETICS
- Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake
- (2011) C. Eiden et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Measurement of Posaconazole, Itraconazole, and Hydroxyitraconazole in Plasma/Serum by High-Performance Liquid Chromatography With Fluorescence Detection
- (2011) Sara L Buckner et al. THERAPEUTIC DRUG MONITORING
- Posaconazole Plasma Concentrations in Critically Ill Patients
- (2011) John Ray et al. THERAPEUTIC DRUG MONITORING
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers
- (2009) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring
- (2009) Jodi M. Lestner et al. CLINICAL INFECTIOUS DISEASES
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
- (2008) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started